20:11:12 EDT Fri 18 Jul 2025
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

Q:GCTK - GLUCOTRACK INC - https://glucotrack.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
GCTK - Q0.18.01·8.081.45.83-0.09-1.52,270.014,6549,9255.92  6.28  5.513,755.9937  5.1119:53:00Jul 0815 min RT 2¢

Recent Trades - Last 10 of 9925
Time ETExPriceChangeVolume
19:53:08Q8.0122.092100
19:53:08Q8.042.121
19:53:08Q8.032.1120
19:53:06Q8.052.132
19:53:02Q8.052.13130
19:53:00Q8.052.138
19:52:58Q8.052.13100
19:52:56Q8.052.135
19:52:51Q8.032.1164
19:52:51Q8.032.11152

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2025-07-08 08:30U:GCTKNews ReleaseGlucotrack Announces Repurchase of Series A Warrants
2025-06-25 08:30U:GCTKNews ReleaseGlucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
2025-06-12 09:05U:GCTKNews ReleaseGlucotrack Announces Reverse Stock Split Shareholder Approved Action Meets NASDAQ Panel Hearing Listing Requirements
2025-06-04 08:30U:GCTKNews ReleaseGlucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association's 85th Scientific Sessions
2025-05-28 08:30U:GCTKNews ReleaseGlucotrack Strengthens Board of Directors with Election of Victoria E. Carr-Brendel, PhD
2025-05-20 08:30U:GCTKNews ReleaseGlucotrack Establishes Patient Advisory Board to Inform Diabetes Technology Development
2025-05-14 17:10U:GCTKNews ReleaseGlucotrack Reports First Quarter 2025 Financial Results and Recent Corporate Highlights
2025-05-13 08:01U:GCTKNews ReleaseGlucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor
2025-04-16 08:00U:GCTKNews ReleaseGlucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
2025-04-03 08:01U:GCTKNews ReleaseGlucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor
2025-03-31 17:00U:GCTKNews ReleaseGlucotrack Reports Full Year 2024 Financial Results and Recent Corporate Highlights
2025-03-19 08:01U:GCTKNews ReleaseGlucotrack to Present First-In-Human Study Results for Continuous Blood Glucose Monitor at the 2025 International Conference on Advanced Technologies & Treatment for Diabetes
2025-02-26 08:01U:GCTKNews ReleaseGlucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP as New Medical Advisory Board Member
2025-02-04 12:25U:GCTKNews ReleaseGlucotrack, Inc. Announces Pricing of $3.0 Million Public Offering
2025-02-04 08:01U:GCTKNews ReleaseGlucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor
2025-01-30 08:00U:GCTKNews ReleaseGlucotrack Announces Reverse Stock Split
2025-01-29 09:00U:GCTKNews ReleaseGlucotrack Strengthens Leadership Team with Appointment of New Chief Financial Officer
2025-01-21 08:01U:GCTKNews ReleaseGlucotrack Announces ISO 13485:2016 Certification
2025-01-15 08:01U:GCTKNews ReleaseGlucotrack Strenghtens Leadership Team with Addition of Industry Veteran as Vice President of Regulatory Affairs
2025-01-07 16:05U:GCTKNews ReleaseGlucotrack to Present at TechBio Showcase(TM) 2025